Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-11-001720
Filing Date
2011-03-24
Accepted
2011-03-24 17:24:02
Documents
15
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT helix_10k-123110.htm 10-K 1899217
2 ex10-1b.htm EX-10.1(B) 147051
3 ex10-1c.htm EX-10.1(C) 47940
4 ex10-1d.htm EX-10.1(D) 48781
5 ex10-3d.htm EX-10.3(D) 40802
6 ex10-11a.htm EX-10.11(A) 20497
7 ex10-14c.htm EX-10.14(C) 49725
8 ex10-17a.htm EX-10.17(A) 212887
9 ex10-21.htm EX-10.21 37121
10 ex23-1.htm EX-23.1 3434
11 ex31-1.htm EX-31.1 16365
12 ex31-2.htm EX-31.2 16418
13 ex32-1.htm EX-32.1 6109
14 ex32-2.htm EX-32.2 6051
15 ex10-17a_image.jpg GRAPHIC 3259
  Complete submission text file 0001437749-11-001720.txt   2558231
Mailing Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021
Business Address 22118 20TH AVE SE SUITE 204 BOTHELL WA 98021 425 402 8400
HELIX BIOMEDIX INC (Filer) CIK: 0000831749 (see all company filings)

EIN.: 912099117 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-20897 | Film No.: 11710257
SIC: 2834 Pharmaceutical Preparations